Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Postoperative Adjuvant Chemoradiation for cSCCHN

NCT01465815 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT01465815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01465815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Postoperative Adjuvant Chemoradiation for cSCCHN
Lead sponsor
OHSU Knight Cancer Institute
Phase
Phase 1/2
Overall status
Withdrawn
Start date
December 31, 2011
Completion date
September 30, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent skin cancer, recurrent squamous cell carcinoma of the lip and oral cavity, squamous cell carcinoma of the skin, stage iii squamous cell carcinoma of the lip and oral cavity, stage iva squamous cell carcinoma of the lip and oral cavity, stage ivb squamous cell carcinoma of the lip and oral cavity